Interleukin2(IL-2)脾動脈内注入によるLymphokine activated killer(LAK)活性誘導の基礎的検討
- People
- Time
- Owner Organization
Kouganzai taisei saibou ni taisuru Lymphokine activated Killer (LAK) saibou no kouka ni kansuru kisoteki kentou
Murine lymphokine-activated killer (LAK) cells : establishment of LAK cell clones, analysis of target cell killing mechanism and application for tumor therapy
Basic studies on local adoptive immunotherapy with lymphokine-activated killer (LAK) cells and it's clinical application to malignant gliomas
Hizou oyobi masshouketsu tankaku saibou yori yuudoushita hito Lymphokine activated killer (LAK) saibou ni okeru pāforin no hatsugen ni kansuru kenkyuu
Kyoukan rinpakyuu yori yuudoushita Lymphokine Activated Killer saibou no rinshou ouyou : shuyou kyokusho bishou kankyou kaizen no kufuu
In vitroにおける抗癌剤によるLymphokine activated killer(LAK)細胞の殺細胞効果に与える影響
PGI[2]誘導体(セパプロスト・アルファデックス)を封入したリポソームを用いた動脈硬化性変化抑制に関する基礎的研究
LAK細胞誘導に及ぼす各種mitogenの影響に関する検討 : 特に健常者, 消化器癌 (肝細胞癌, 大腸癌) 症例におけるLAK細胞の増殖能, 細胞障害活性およびリンパ球細胞表面マーカーに及ぼす影響について
Last Updated:
Uploaded: 2020-12-17